{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:50:14Z","timestamp":1790182214991,"version":"4.1.0"},"reference-count":37,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Transplantation of whole bone marrow (BMT) as well as ex vivo\u2013expanded mesenchymal stromal cells (MSCs) leads to striking clinical benefits in children with osteogenesis imperfecta (OI); however, the underlying mechanism of these cell therapies has not been elucidated. Here, we show that non\u2013(plastic)\u2013adherent bone marrow cells (NABMCs) are more potent osteoprogenitors than MSCs in mice. Translating these findings to the clinic, a T cell\u2013depleted marrow mononuclear cell boost (&gt; 99.99% NABMC) given to children with OI who had previously undergone BMT resulted in marked growth acceleration in a subset of patients, unambiguously indicating the therapeutic potential of bone marrow cells for these patients. Then, in a murine model of OI, we demonstrated that as the donor NABMCs differentiate to osteoblasts, they contribute normal collagen to the bone matrix. In contrast, MSCs do not substantially engraft in bone, but secrete a soluble mediator that indirectly stimulates growth, data which provide the underlying mechanism of our prior clinical trial of MSC therapy for children with OI. Collectively, our data indicate that both NABMCs and MSCs constitute effective cell therapy for OI, but exert their clinical impact by different, complementary mechanisms. The study is registered at www.clinicaltrials.gov as NCT00187018.<\/jats:p>","DOI":"10.1182\/blood-2011-12-400085","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T02:13:33Z","timestamp":1343182413000},"page":"1933-1941","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":123,"title":["Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms"],"prefix":"10.1182","volume":"120","author":[{"given":"Satoru","family":"Otsuru","sequence":"first","affiliation":[{"name":"Division of Oncology\/Blood and Marrow Transplantation, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Transplantation and Gene Therapy Program, St Jude Children's Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Shimono","sequence":"additional","affiliation":[{"name":"Division of Orthopedics, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Jethva","sequence":"additional","affiliation":[{"name":"Division of Oncology\/Blood and Marrow Transplantation, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Marino","sequence":"additional","affiliation":[{"name":"Division of Oncology\/Blood and Marrow Transplantation, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA;"},{"name":"Transplantation and Gene Therapy Program, St Jude Children's Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Missouri, Columbia, MO; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted J.","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Division of Oncology\/Blood and Marrow Transplantation, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA;"},{"name":"Transplantation and Gene Therapy Program, St Jude Children's Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Veronesi","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, University-Hospital of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, University-Hospital of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Division of Orthopedics, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin M.","family":"Horwitz","sequence":"additional","affiliation":[{"name":"Division of Oncology\/Blood and Marrow Transplantation, The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA;"},{"name":"Transplantation and Gene Therapy Program, St Jude Children's Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111810064410100_B1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1172\/JCI117738","article-title":"Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors [published erratum appears in J Clin Invest. 1995;96(5):2541].","volume":"95","author":"Long","year":"1995","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111810064410100_B2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI114852","article-title":"Expression of human bone-related proteins in the hematopoietic microenvironment.","volume":"86","author":"Long","year":"1990","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111810064410100_B3","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1073\/pnas.92.11.4857","article-title":"Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice.","volume":"92","author":"Pereira","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111810064410100_B4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","article-title":"Characterization of cells with osteogenic potential from human marrow.","volume":"13","author":"Haynesworth","year":"1992","journal-title":"Bone"},{"issue":"3","key":"2019111810064410100_B5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat Med"},{"issue":"4","key":"2019111810064410100_B6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1084\/jem.189.4.729","article-title":"Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice.","volume":"189","author":"Nilsson","year":"1999","journal-title":"J Exp Med"},{"issue":"4","key":"2019111810064410100_B7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"5","key":"2019111810064410100_B8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood.V97.5.1227","article-title":"Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta.","volume":"97","author":"Horwitz","year":"2001","journal-title":"Blood"},{"issue":"7","key":"2019111810064410100_B9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.exphem.2010.04.008","article-title":"Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies.","volume":"38","author":"Mehrotra","year":"2010","journal-title":"Exp Hematol"},{"issue":"3","key":"2019111810064410100_B10","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1073\/pnas.95.3.1142","article-title":"Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta.","volume":"95","author":"Pereira","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2019111810064410100_B11","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone.","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"2019111810064410100_B12","doi-asserted-by":"crossref","first-page":"11761","DOI":"10.1073\/pnas.0404626101","article-title":"Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation.","volume":"101","author":"Dominici","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"2019111810064410100_B13","doi-asserted-by":"crossref","first-page":"15877","DOI":"10.1073\/pnas.2632959100","article-title":"Primitive adult hematopoietic stem cells can function as osteoblast precursors.","volume":"100","author":"Olmsted-Davis","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2019111810064410100_B14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.exphem.2010.04.005","article-title":"Hematopoietic stem cell origin of connective tissues.","volume":"38","author":"Ogawa","year":"2010","journal-title":"Exp Hematol"},{"issue":"1","key":"2019111810064410100_B15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/gene.20121","article-title":"Transgenic mice with pancellular enhanced green fluorescent protein expression in primitive hematopoietic cells and all blood cell progeny.","volume":"42","author":"Dominici","year":"2005","journal-title":"Genesis"},{"issue":"3","key":"2019111810064410100_B16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2007.11.002","article-title":"Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment.","volume":"36","author":"Marino","year":"2008","journal-title":"Exp Hematol"},{"issue":"11","key":"2019111810064410100_B17","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood-2008-10-183459","article-title":"Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation.","volume":"114","author":"Dominici","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111810064410100_B18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymgme.2011.07.025","article-title":"Deficient degradation of homotrimeric type I collagen, alpha1(I)3 glomerulopathy in oim mice.","volume":"104","author":"Roberts-Pilgrim","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2019111810064410100_B19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1074\/jbc.M109.053926","article-title":"Wnt\/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover.","volume":"285","author":"Yasuhara","year":"2010","journal-title":"J Biol Chem"},{"issue":"4","key":"2019111810064410100_B20","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1634\/stemcells.2005-0260","article-title":"Local irradiation induces not only homing of human mesenchymal stem cells (hMSC) at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution following irradiation damages.","volume":"24","author":"Francois","year":"2006","journal-title":"Stem Cells"},{"issue":"12","key":"2019111810064410100_B21","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1002\/art.10696","article-title":"Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells.","volume":"46","author":"Jones","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2019111810064410100_B22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1465-3249(05)70787-8","article-title":"Mesenchymal stem cells: progress toward promise.","volume":"7","author":"Le Blanc","year":"2005","journal-title":"Cytotherapy"},{"issue":"8","key":"2019111810064410100_B23","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood-2007-10-115725","article-title":"Donor cell-derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation.","volume":"111","author":"Dominici","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111810064410100_B24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(85)80501-1","article-title":"Clinical longitudinal standards for height and height velocity for North American children.","volume":"107","author":"Tanner","year":"1985","journal-title":"J Pediatr"},{"issue":"9418","key":"2019111810064410100_B25","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta.","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"2019111810064410100_B26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jmg.28.7.433","article-title":"Osteogenesis imperfecta: translation of mutation to phenotype.","volume":"28","author":"Byers","year":"1991","journal-title":"J Med Genet"},{"issue":"33","key":"2019111810064410100_B27","doi-asserted-by":"crossref","first-page":"25162","DOI":"10.1016\/S0021-9258(19)74583-9","article-title":"Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain. A regional model relating mutation location with phenotype.","volume":"268","author":"Wang","year":"1993","journal-title":"J Biol Chem"},{"issue":"5","key":"2019111810064410100_B28","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","article-title":"Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.","volume":"90","author":"Chipman","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2019111810064410100_B29","first-page":"194","article-title":"Bone growth in length and width: the yin and yang of bone stability.","volume":"5","author":"Rauch","year":"2005","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"8","key":"2019111810064410100_B30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/14653240802618085","article-title":"How do mesenchymal stromal cells exert their therapeutic benefit?","volume":"10","author":"Horwitz","year":"2008","journal-title":"Cytotherapy"},{"issue":"21","key":"2019111810064410100_B31","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2013the material and structural basis of bone strength and fragility.","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111810064410100_B32","first-page":"670","article-title":"Phenotypic heterogeneity in osteogeneisi imperfecta: the mildly affected mother of a Proband with a lethal variant has the same mutation substituting cysteine for a1-glycine 904 in a type I procollagen gene (COL1A1).","volume":"47","author":"Constantinou","year":"1990","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2019111810064410100_B33","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1074\/jbc.M109048200","article-title":"Procollagen with skipping of alpha 1(I) exon 41 has lower binding affinity for alpha 1(I) C-telopeptide, impaired in vitro fibrillogenesis, and altered fibril morphology.","volume":"277","author":"Cabral","year":"2002","journal-title":"J Biol Chem"},{"issue":"5309","key":"2019111810064410100_B34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues.","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"issue":"5411","key":"2019111810064410100_B35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells.","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"1","key":"2019111810064410100_B36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.20051714","article-title":"Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning.","volume":"203","author":"Bhattacharya","year":"2006","journal-title":"J Exp Med"},{"issue":"2","key":"2019111810064410100_B37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1359\/jbmr.2003.18.2.237","article-title":"Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.","volume":"18","author":"Marini","year":"2003","journal-title":"J Bone Miner Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/9\/1933\/1363646\/zh803512001933.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/9\/1933\/1363646\/zh803512001933.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T13:03:58Z","timestamp":1687611838000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/9\/1933\/30925\/Transplanted-bone-marrow-mononuclear-cells-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,30]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,8,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-12-400085","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717953258.793458834","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,30]]}}}